Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This is a phase I/II study investigating the combination of 225Ac-J591 (a drug that can deliver radiation to prostate cancer cells) with pembrolizumab (immunotherapy, a drug that increases the immune system's ability to destroy cancer cells). This study will assess whether 225Ac-J591 + pembrolizumab + androgen receptor inhibitor (ARI) is more effective against prostate cancer than pembrolizumab + ARI alone.
Sponsor: Weill Medical College of Cornell University
Check if you qualify for this prostate cancer clinical trial in Boston, MA
If you're searching for prostate cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.